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Abstract
Introduction A general detrimental effect of smoking
during pregnancy on the health of newborn children is
well-documented, but the detailed mechanisms remain
elusive.
Objectives Beside the specific influence of environ-
mental tobacco smoke derived toxicants on developmental
regulation the impact on the metabolism of newborn chil-
dren is of particular interest, first as a general marker of
foetal development and second due to its potential pre-
dictive value for the later occurrence of metabolic diseases.
Methods Tobacco smoke exposure information from a
questionnaire was confirmed by measuring the smoking
related metabolites S-Phenyl mercapturic acid, S-Benzyl
mercapturic acid and cotinine in maternal urine by LC–
MS/MS. The impact of smoking on maternal endogenous
serum metabolome and children’s cord blood metabolome
was assessed in a targeted analysis of 163 metabolites by
an LC–MS/MS based assay. The anti-oxidative status of
maternal serum samples was analysed by chemoluminis-
cence based method.
Results Here we present for the first time results of a
metabolomic assessment of the cordblood of 40 children
and their mothers. Several analytes from the group of
phosphatidylcholines, namely PCaaC28:1, PCaaC32:3,
PCaeC30:1, PCaeC32:2, PCaeC40:1, and sphingomyelin
SM C26:0, differed significantly in mothers and children’s
sera depending on smoking status. In serum of smoking
mothers the antioxidative capacity of water soluble com-
pounds was not significantly changed while there was a
significant decrease in the lipid fraction.
Conclusion Our data give evidence that smoking during
pregnancy alters both the maternal and children’s meta-
bolome. Whether the different pattern found in adults
compared to newborn children could be related to different
disease outcomes should be in the focus of future studies.
Electronic supplementary material The online version of this
article (doi:10.1007/s11306-016-0983-z) contains supplementary
material, which is available to authorized users.
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Abbreviations
ACL Antioxidative capacity of lipid soluble
compounds
ACW Antioxidative capacity of water soluble
compounds
CB Cord blood
GW Gestational week
S Smoke burdened
lysoPC Lysophosphatidylcholines
NS No smoke burden
PC Phosphatidylcholines (a, a-diacyl form; a, e acyl-
ether form)
SM Sphingomyelines
SBMA S-Benzyl mercapturic acid
SPMA S-Phenyl mercapturic acid
1 Introduction
With about 250 million smoking women worldwide natu-
rally also a huge number of newborn children are affected
by tobacco smoke. Many components of tobacco smoke
have been shown to cross the placenta (Jordanov 1990) and
for nicotine even a concentrating effect in the foetal blood
was found. Prenatal tobacco smoke exposure is regarded as
the most frequent avoidable cause of adverse health effects
on the foetus such as preterm birth and intrauterine growth
retardation (Ward et al. 2007; Windham et al. 2000).
Furthermore a correlation between maternal smoking and
the risk for developing obesity in the offspring has been
reported in epidemiological studies (Oken et al. 2005).
Since the mechanistic link between prenatal tobacco smoke
exposure and overweight development of the child still
remains unclear profiling the metabolome of the affected
children seems to be a reasonable strategy.
The effect of smoking on serum metabolites in adults has
been described by Wang-Sattler et al. (2008a) using a tar-
geted approach that detected and quantified 198 endogenous
metabolites. In that study the groups of current smokers were
clearly discriminated from non-smokers, whereas the former
smokers were only partially separated by multivariate anal-
ysis. The strongest metabolite concentration differences
were found for phosphatidylcholines, which belong to fatty
acid metabolism. Within this larger group of phosphatidyl-
cholines especially the balance between the acyl–acyl and
the acyl-alkyl forms was affected.
The assessment of the metabolomic changes in a limited
volume of fetal blood became possible with the advent of
highly sensitive mass spectrometry devices. To the best of
our knowledge, this technique has so far only once been
applied in one newborn study focussing on metabolomic
profiles of children with intrauterine growth restriction
(Favretto et al. 2012). Favretto et al. used an untargeted LC–
MS approach and detected many peaks that provided hints
for clear separation between controls and those newborn
children with restricted growth based on principal compo-
nent analysis. Among others, the essential amino acids
phenylalanine, tryptophan, and methionine were identified
to be differentially abundant in children with restricted
intrauterine growth vs controls. In further studies the meta-
bolome profile occurring upon intrauterine growth restric-
tion has been analysed in pigs (Nissen et al. 2011;
Rudashevskaya et al. 2012) by applying NMR. In these
studies the difference between normal foetal weight and low
foetal weight were pinpointed to a broad range of alterations
from amino acids to various molecules in lipid metabolism.
The potential of screening approaches lies in their
inherent potential to discover alterations in so far unex-
pected metabolites. On the other hand, in untargeted
approaches many peaks are hard to identify why the full
potential in terms of coverage is seldom fully tapped. For
assessing the metabolome of the maternal and foetal blood
of non- and smoking mothers we decided to use a highly
similar and thereby comparable targeted approach as
applied by Wang-Sattler et al. (2008a) for the characteri-
zation of nicotine dependent metabolome changes in an
adults. Since a highly similar measurement was used in
both studies the data will be well comparable.
The samples were collected in the framework of a
prospective cohort study designed for the investigation of
prenatal environmental exposure on the risk of the child for
developing atopic diseases (Herberth et al. 2011). In this study
the parental smoking habit is assessed by questionnaire. In
addition, tobacco-smoke related metabolites (S-phenyl mer-
capturic acids as specificmetabolite for benzene and S-benzyl
mercapturic acid as specific metabolite of toluene) were
analysed in maternal urine at the 34th week of gestation.
Benzene and toluene are volatile components of tobacco
smoke and smoking is regarded as themain source of benzene
in indoor air. Urinary mercapturic acids were described as
biomarkers for exposure in the early 1990s (De Rooij et al.
1998; Haufroid and Lison 2005) and the validity of them has
been demonstrated in numerous studies (Inoue et al. 2004;
Takahashi et al. 1994), (Barbieri et al. 2008; Rolle-Kampczyk
et al. 2002).As environmental tobacco smoke (ETS) is known
to cause oxidative stress, we also tested for the antioxidative
capacity in the serum of the mothers.
Beyond the measurement there is an urgent need for
developing evaluation tools of metabolome data. The
classical way of calculating significant changes between
single metabolites in different conditions and presentation
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of principal component analysis plots provides the basic
analysis but does not tap the full potential of interpreting
high dimensional metabolome data. For further analysis
first the data-driven correlation analysis is important to
identify co-regulation of metabolites. However, this has to
be corrected by biochemical connectivity in order to gen-
erate pathway dependent information which is much more
robust than single biomarker based monitoring of cellular
reactions Krumsiek et al. (2011a; Wang-Sattler et al.
2008a).
For the first time we are describing here the cord blood
metabolome and the impact of prenatal tobacco smoke
exposure on the foetal metabolism. Obtained results may
help to explain the link between prenatal exposure to
smoke contaminants and the metabolomic programming of
the children.
The following hypotheses can be formulated:
1. Mothers and newborn children show a similiar
metabolom regulation.
2. Metabolic changes are detectable for mothers and
newborns depending on the motheŕs smoking behavior.
3. It is possible to show different concentrations of the
smoking related metabolites S-phenyl and S-benzyl
mercapturic acid and cotinine.
4. The antioxidative status is smoke burdened associated.
2 Material and methods
2.1 Study design
The LINA study (Lifestyle and Environmental Factors and
their Influence on Newborn Allergy risk) was designed to
investigate the prenatal influence of life style and envi-
ronmental factors on the maturation of the immune system
and the resulting risk in developing atopic diseases in
infancy. 629 mother–child pairs (622 mothers; 7 twin pairs)
were recruited in Leipzig, Germany in the Children’s
Hospital ‘‘St. Georg’’ between May 2006 and December
2008 (Herberth et al. 2011). Information on the mother‘s
and father‘s allergy status, living conditions, and environ-
mental exposure was gathered by way of questionnaires.
The smoking mothers were slightly younger than the
smoke-free mothers (27.4 years vs 30.4 years). The
smoking behaviour was included in the analysis as a con-
founding factor. Parental asthma was included as a con-
founder with other confounding factors. We do not have
information on parental diabetes. One inclusion criterion
for the study was: no persistent disorders. Therefore med-
ication on a regular basis (i.e. during pregnancy) is
uncommon in our cohort. We removed all participants who
could not fulfill inclusion criteria.
We defined exclusion criteria, namely the diagnosis of
asthma and diabetes, and furthermore we excluded these
persons who showed drug abuse, as detected in a recent
study (Hoeke et al. 2015).
During a clinical visit at the 34th week of pregnancy
venous blood and urine samples were collected from the
mother. After birth, cord blood was obtained by venous
puncture. Participation in the study was voluntary. Written
informed consent was obtained from the parents. The study
was approved by the Ethics Committee of the University of
Leipzig (reference number 046-2006).
For this study a subsample of 35 mother child pairs (17
smoking and 18 non-smoking mothers and their children
and ever 2 smoking and non-smoking mother and one
additional smoke burdend child) was randomly selected.
For differentiation in non-smoker and smoker group we
used information from questionnaires as well as the urine
cotinine level (above 30 lg cotinine/g creatinine for the
smoke burdened group). The here studied subgroup of
children contains 28 boys (70 %) and 12 girls (30 %), from
which 31 (77 %) were born spontaneous. The average birth
weight was 3434 g (range 2610–4165 g). Only full term
neonates, born after 37th week of gestation with a birth
weight above 2.500 g were included into this analysis.
2.2 Material sampling
Urine was personal sampled as morning urine by mothers
self on the day of house visits. After that the samples were
transferred to the lab, than sterile filtered deep frozen
(-80 C) up to analysis.
Motheŕs blood were collected during consultation hour
(34th week of gestation). Cord blood samples were col-
lected during birth in maternity room and handled as
described elsewhere (Hinz et al. 2012). In brief, serum was
prepared immediately and samples were transferred to and
stored in -80 C deep freezer up to analysis. An inter-
ruption of freezing can be excluded by authors.
2.3 Determination of smoking-related exogenous
metabolites and the oxidative status of serum
samples
The measurement of tobacco smoke metabolites in
maternal urine was performed as described elsewhere
(Rolle-Kampczyk et al. 2006). The anti-oxidative status of
maternal serum samples was analysed by PhotochemR
(Analytic Jena, Germany). After calibration using stan-
dards provided by the supplier 10 ll of serum were mixed
with 2290 ll working solution 1. Afterwards 200 ll reac-
tion buffer and 25 ll stock solution was added. The total
mixture was then placed into the sampling device and
immediately measured. The instrument uses the calibration
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for internal calculation of standardized values of antioxi-
dant capacity.
2.4 Assessment of endogenous metabolites
The metabolome analyses were carried out using the
AbsoluteIDQ p150 Kit (Biocrates Life Science AG,
Innsbruck, Austria) as described elsewhere (Oberbach et al.
2012). In brief, 10 lL of serum were mixed with internal
standard and dried under nitrogen. Subsequently the
metabolites were derivatized with phenylisothiocyanate
(PITC) 5 % for 20 min at room temperature and dried for
30 min under nitrogen flow. For extraction first 300 lL of
extraction solvent (5 mM ammonium acetate in methanol)
were added and incubated with shaking at 450 rpm
(Thermomixer comfort Eppendorf, Hamburg, Germany)
for 30 min at room temperature followed by filtration by
centrifugation (Sigma 2–16 k, Taufkirchen, Germany) for
2 min at 500 9 g. From the filtrate 100 lL were mixed
with 500 ll of MS running buffer and 20 lL were sub-
jected for flow injection analysis-MS/MS measurements
(FIA-MS/MS). MS measurements were performed on a
QTRAP mass spectrometer applying electrospray ioniza-
tion (ESI) (ABI Sciex API5500Q-TRAP). Identification
and quantification were achieved by multi reaction moni-
toring (MRM) standardized by applying spiked-in iso-
topically labelled standards in positive and negative mode,
respectively. For calibration a calibrator mix consisting of
7 different concentrations was used. Quality controls were
included for 3 different concentration levels. For FIA an
isocratic method was used (100 % organic running solvent)
with varying flow conditions (0 min, 30 lL/min; 1.6 min
30 lL/min; 2.4 min, 200 lL/min; 2.8 min, 200 lL/min;
3 min 30 lL/min), and the MS settings were as follows:
Scan time 0.5 s, IS voltage for positive mode 5500 V, for
negative mode -45,000 V, nitrogen as collision gas med-
ium, source temperature 200 C. The integrated MetIDQ
software (Biocrates, Innsbruck, Austria) streamlines data
analysis by automated calculation of metabolite concen-
trations providing quality measures and quantification.
2.5 Data evaluation and statistical analysis
Statistical analyses were performed using the R platform
version 2.14.1 (http://www.r-project.org). Besides the basic
packages in R, we used Car, Coin, Corrgram, Gdata and
Psych. Non parametric Wilcoxon tests were performed for
each analyte to check for significant differences between
the two considered groups. Pearson’s correlation coeffi-
cients were determined to analyse pair wise correlation of
the metabolites. For PCA and clustering, the concentrations
of the samples have been scaled to mean = 0 and standard
deviation = 1. The PCA was calculated via the princomp
function in R while clustering is performed by the hclust
function based on the Euclidean distances of the
concentrations.
2.6 Differential correlation analysis
Before differential correlation analysis, a quality control
procedure was applied in order to avoid false negatives and
spurious correlations. First, variables with more than 50 %
of values below the detection limit were excluded. Second,
we removed outlier samples that deviate more than 3
standard deviations from the respective mean for at least
one metabolite. After these preprocessing steps the data
matrix contained 60 metabolites and 75 samples. Pairwise
Pearson correlations for the four groups (mother/smoker,
mother/non-smoker, cord blood/smoker, cord blood/non-
smoker) were calculated separately and differential corre-
lation analysis between groups was performed. The sig-
nificance of correlation differences between two groups A
and B for two given metabolites i and j was assessed by the
following test statistic:
TABij ¼
z qAij
 
 z qBij
 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
nA3 þ
1
nB3
q ;
where qij
A and qij
B represent the Pearson correlations between i
and j in the respective groups, nA and nB are the sample sizes
of both groups, and z(  ) represents the Fisher transforma-
tion z xð Þ := 1
2
ln 1þx
1x
 
. Tij
AB is approximately standard nor-
mally distributed. A two-sided p value can be derived from
the respective quantile of the standard normal distribution.
3 Results
In order to analyse clearly defined groups the mothers were
selected according to their questionnaire answers on their
smoking habit (Herberth et al. 2011; Hinz et al. 2010). In
addition to questionnaire information, the current maternal
tobacco smoke exposure status was validated by chemical
assessment of the smoking-derived metabolites S-phenyl
mercapturic acids, S-benzyl mercapturic acid, and cotinine
in the urine collected at 34th week of gestation.
The urine concentrations of the benzene and toluene
derivates S-phenyl mercapturic acids (SPMA: 0.71 ± 0.92
vs 0.58 ± 0.53 lg/g creatinine) and S-benzyl mercapturic
acid (SBMA: 6.08 ± 2.8 vs 6.60 ± 9.31 lg/g creatinine)
did not differ significantly between smokers and non-
smokers (Fig. 1). Cotinine is the utmost important nicotine
metabolite Benowitz et al. (2009) and has been proven to be a
suitablemarker to differentiate between smoke burdened and
unburdened persons (Benowitz 1996). Here we found clear
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differences between non-smokers (2.12 ± 2.07 lg/g crea-
tinine) and smokers (411.37 ± 351.41 lg/g creatinine) that
are highly significant (p = 2 9 10-7). Also the correlation
between the questionnaire items on smoking/ETS exposure
and urine cotinine levels was positive (R = 0.65, spearman’
rank correlation).
Another reported consequence of smoking is oxidative
stress (Zalata et al. 2007). To further confirm the effects of
smoking we analysed the antioxidant capacity in the serum.
The maternal blood was analysed by a chemoluminiscence
based method making use of the fast photochemical excita-
tion of radical formation combined with sensitive lumino-
metric detection. The water soluble antioxidant capacity
(ACW) measurements summarize the effects of ascorbinic
acid, uric acid and bilirubine. The lipid soluble capacity
(ACL) represents the aggregated antioxidative capacity of ß-
carotine, Q10-Enzyme and tocopherol. In this study we
found no significant difference in the water soluble fraction
between smoking and non-smoking mothers (1.49 ±
0.43 mmol/mL non-smoker group vs 1.3 ± 0.42 mmol/mL
smoker group). In contrast, the antioxidative potential in the
lipid soluble fraction was higher in the serum of non-smok-
ing mothers (2.12 ± 0.32 mmol/mL) compared to the
smoking group (1.89 ± 0.26 mmol/mL, p = 0.015, Fig. 1).
In order to obtain information on whether smoking of
the mother affects their own and the foetal endogenous
metabolism, serum samples from the mothers and cord
blood samples were analysed using a targeted metabo-
lomics approach. This approach allows assessing 163
parameters from the substance classes of amino acids,
acylcarnitines, hexoses, phosphatidylcholines and sphin-
gomyelines. Based on PCA, the main cause for the vari-
ance (45 %) is based on the difference between mother and
cord blood while there is no clear differentiation for all
metabolites between the smoking and non-smoking groups.
The stark differences between mother and cord blood are
indicated by very low p-values for both the smoking and
non-smoker samples (Fig. 2a, b). In both sample sets the
maternal serum contains for example more Orn, SMC 24:0
and short chain PCaa/PCae, whereas the cord blood
showed increased levels of Gln, Met and C18:2.
Beside the general differences the direction of the
smoking-related changes is opposite in the two sample sets,
mostly negative in children and mostly positive in the
mothers. These results were validated by multiple mea-
surements. Although this mirrored appearance is interest-
ing we will focus in this study on the effects of smoking on
the endogenous metabolome as such.
Significant differences caused by smoking were found in
different substance classes. Both the diacyl- as well as the
acyl-ether phospholipids was determined as the most
strongly affected substance classes, followed by the acyl
carnitines and amino acids. More specifically, 23
significantly different abundant endogenous metabolites
were found for the mothers and 25 for the foetus group in
dependency to the smoking habit of the mother. For the 6
metabolites that were affected in both of the groups
(PCaaC28:1, PCaaC32:3, PCaeC30:1, PCaeC32:2,
PCaeC40:1, and SM C 26:0) detailed information is pro-
vided in the supplemental tables S1 and S2 and in Fig. 3. In
the maternal samples smoking is related with an up regu-
lation of amino acids and a down regulation of PCaa and
PCae and SM molecules. In the foetal samples smoking
increases all parameters, namely PCaa, PCae and SM, with
the exception of acylcarnitines which were significantly
down regulated.
In the next step of evaluation the correlation among the
different metabolites within the groups of smoking mothers
(supplemental Figure S1) and cord blood samples of the
tobacco smoke exposed children (supplemental Figure S2)
was analysed (see also Fig. 4). In the samples from the
mothers positive correlations were detected for several
groups of metabolites, namely for amino acids (group 1,
Arg, Gln, Gly, His, Met, Thre, Trp and Tyr) the phos-
phatidylcholines with residues ranging from 28 to 44 and
various acyl- and alkyl combinations (group 2), the set of
lysophosphatidylcholines (group3) and the sphingomyeli-
nes (group 4). In the cord blood samples nearly the same
groups were detected but the group of phosphatidylcholines
was less well separated and also the group of lysophos-
phatidylcholines showed weaker correlations. For the
group of amino acids the correlation nearly vanished. In
addition to the groups found in the adults one additional
group of positively correlating analytes, the carnitines were
detected (Figure S2, group 5, C14:1, C15, C15:1, C18:1,
C18:2, C2, C3, C3-DC/C4-OH, and C4).
In addition to the regular correlation approach, we
inferred a Gaussian graphical model (GGM) from our
metabolomics dataset. GGMs are based on partial corre-
lation coefficients, which inherently eliminate indirect
effects in the dataset and have been shown to recover
metabolic pathways from plasma metabolomics data
recently (Krumsiek et al. 2011a). The GGM was calculated
on the combined dataset including all conditions, but cor-
rected for confounding effects of mother and cord blood
samples as well as smoking. The resulting network can be
regarded as an interaction network capturing intrinsic
metabolic relationships irrespective of the investigated
phenotypes. An edge was included in the model if the
respective partial correlation was significantly different
from zero with a = 0.01 after FDR correction. The final
network contained 123 nodes (one for each metabolite) and
91 out of 7503 theoretically possible edge (1.2 %
connectivity).
In the following, we describe three selected subnetworks
and smoking-related changes in both mothers and children
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(see supplementary material Figure S3). The first subnet-
work comprises the five amino acids glutamine, tyrosine,
methionine, phenylalanine and glycine and their recon-
structed biochemical interactions (Figure S3-A). We
observe a moderate, but coordinate up-regulation of these
five amino acids upon smoking in mothers, whereas the
same metabolites show lower concentrations in cord blood.
An opposite effect can be seen for the phospholipid net-
work shown in Figure S3-B. In this case, we observe a
slight decrease upon smoking in mothers and an increase in
cord blood. Similarly, the phospholipid network in Fig-
ure S3-C provides another evidence for a coordinate down-
regulation of phospholipids in mothers and an up-regula-
tion in cord blood for the smoking group. Interestingly, the
GGM predicts an interaction between PCaaC32:3 and
propionylcarnitine (C3) as well as free carnitine (C0),
which show little to no effects with respect to smoking.
4 Discussion
4.1 Comparison to other nicotine dependent
endogenous biomarkers
It is well known that cigarette smoke or passive smoking
can have negative health effects. Around 4700 chemicals
could be found in cigarette smoke (Repine, The Oxidative
Stress Study 1997). The markers of SPMA and SBMA
failed for separating the groups judged by statistics. In
respect to SPMA, which is more often used due to the
higher concentration of benzene in tobacco, smoke, this is
in accordance to Barbieri et al. (2008) where also no cor-
relation of the smoking habit and the SPMA levels were
detected. But other studies have shown a correlation
(Lovreglio et al. 2013) (Protano et al. 2010) (Lv et al.
2014). One possible explanation of this contradiction might
be the different levels of exposure in those studies. In
contrast cotinine is a reliable marker for smoking and the
correlation has been established in many studies Benowitz
et al. (2009) (Mattsson et al. 2015) (Martinez-Sanchez
et al. 2014) The degree of correlation with the self-report
questionnaires is in agreement with a recent study (Park
et al. 2015) comparing questionnaires and urine sampling
showing a tendency of underreporting in self-reports.
One potential mechanism for various adverse health
effects can be smoke associated oxidative stress by influ-
encing the antioxidant defence system (Alberg 2002). We
confirm here the specific effects on the lipophilic part of the
antioxidative stress response, which is in agree ment/dis-
agreement with (Titova et al. 2012) and (Ardalic et al.
2014).
It was also shown that exposure to nicotine can trigger a
wide range of metabolic changes (Wang-Sattler et al.
2008b). In an evaluation of metabolic profiles of smokers,
former smokers and non-smokers, all men, moreover 23
lipid metabolites were identified as nicotine dependent
biomarkers (Wang-Sattler et al. 2008a). In our study,
including only pregnant women and newborn children,
other smoking-specific metabolic profiles were found. The
accordance to this study in terms of the exact molecules is
Fig. 1 Exogenous metabolites
(S-phenyl mercapturic acid
(SPMA), S-benzyl mercapturic
acid (SBMA) and Cotinine) in
urine of mothers at 34th week of
gestation for non-smoker (NS)
and smoker (S) and
antioxidative status of water
soluble (ACW) and lipid soluble
compounds (ACL) in maternal
blood for non-smoker (NS) and
smoker (S)
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limited, since only one metabolite, PCae40:6 was detected
in both studies as a nicotine-dependent down regulated
biomarker. Beyond PCae40.6 many similar molecules were
identified as tobacco smoke related biomarkers, as for
example PCaa34:3 in our study and the molecules
PCaa34:1and PCaa34:2 by Wang-Sattler et al. More related
molecules were found in the case of PCaa36:5 which was
differential abundant in this study and PCaa36:2, PCaa36:1
and PCaa36:3 which were found by Wang-Sattler et al. In
general, we detected more markers from the acyl-ether
group of PC in our female exposure group, whereas in men
more acyl–acyl forms were identified as tobacco smoke
sensitive (Wang-Sattler et al.). Thereby, the direction of
changes in respect to the PCaa molecules was highly
similar. In both studies all significantly affected PCaa
molecules were found to be upregulated. With respect to
the PCae molecules Wang-Sattler et al. found only down-
regulation while we observed mostly up-regulation in
females.
The differences in these two studies might be due to the
different source of samples, first the data set of Wang-
Sattler et al. was larger especially for the non-smokers (255
not actually smoking people vs 28 actual smokers) and
only male participants were included, whereas we analysed
solely pregnant women and new-borns. A difference
between the metabolism of male and female adult persons
in respect to smoking was shown for total cholesterol,
HDL-C and LDL-C in a recent study (Al-Bazi et al. 2011).
Fig. 2 Volcano Plots of the metabolome profiles of mothers and children for smoker and non-smoker
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A higher sensitivity of female subjects towards tobacco
smoke in terms of lipid metabolism would explain the
differences between this study and the results from Wang-
Sattler et al. In addition, 163 instead of 198 metabolites
were assessed and some of the detected biomarkers were
not included in our measurement, which might have also
influenced the ranking of the biomarkers. We have also
tested the gender dependent differences within the group of
newborns but did not detect any significant differences
between male and female samples. Consequently the gen-
der of the newborns is also not responsible for the large
difference between the mother and the newborns.
The differentially abundant metabolites fall predomi-
nantly into the group of lipids. And in general the con-
centrations of lipids are lowered in the cord blood. This
leads to the hypothesis that the newborns use beside other
nutrients like glucose and amino acids also the normal
spectrum of serum lipids as nutrients.
4.2 Correlations within and between groups
of molecules
The correlation patterns of groups of metabolites underline
the biochemical relations between them. As metabolites
either originate from identical precursors or are trans-
formed by the same enzymes or metabolic pathways they
consequently often correlate in their abundance. Remark-
ably, the correlation patterns in the maternal and the foetal
samples differed, most strongly in the group of carnitines,
which were more strongly correlated in the foetal samples.
The degree of correlation can be also taken as a hint for
regulatory pressure on a group of molecules, since without
it; the abundances can be expected to scatter more widely.
Acyl-carnitines are used in new-born screening for
detecting fatty and organic acid metabolism disorders since
1998 (Marsden et al. 2006). In the foetus the metabolism is
strongly driven towards fat oxidation (Melichar et al.
1965), in which acyl carnitines are crucially involved by
the transport of acyl-CoA into the mitochondria. Thereby a
reduced level of acyl carnitines might lead to a reduced
energy production. The lowering effect of smoking on
carnitine levels in the foetus might be one link in the
mechanistic chain leading to lower birth weights in new-
borns of smoking mothers.
Beside the expected correlation between the PCaa, PCae
and SM groups the correlation between lysophosphatidyl-
cholines on the one hand and the amino acids Gln, Gly, His
and Met on the other hand was surprising. The link
between lysophosphatidylcholines and glutamine was
reported to be caused by the simultaneous induction of
glutamine synthase and the increase of glycerol incorpo-
ration into arachidonic acid as a result of stimulating
Fig. 3 Smoke-dependent
(S smoker, NS non-smoker)
significantly affected
metabolites of mothers at 34th
week of gestation (34GW) and
cord blood (CB)
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glioma cells (Sun et al. 1997). Glutamine has also been
reported to be involved in glucose and glycogen metabo-
lism, immune system function and the maintenance of
skeletal muscle (Antonio and Street 1999). Glutamine is
linked with histidine synthesis via glutamate, which was
not determined in this assay, so this linkage remains
hypothetical.
Glycine is involved in many different biochemical
mechanisms including the regulation of plasma cholesterol
and triglyceride levels (Ratnayake et al. 1997), but the
specific linkage to lysophosphatidylcholines and not to
other molecules from the fatty acid metabolism will require
further investigation.
4.3 Origin of biomarkers in the endogenous
metabolome and metabolomic programming
The first hindrance of a straight-forward interpretation of
serum metabolome studies lies in the uncertain origin of
the metabolites. Only a minority of metabolites is reported
Fig. 4 Correlations of
metabolites between smokers
(blue) and non-smokers (green)
for mother (a, b and c) and cord
blood (d, e and f) (Color
figure online)
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to be produced in the serum itself, instead most stem from
liver, skeletal muscle, fat tissue and brain (Suhre et al.
2010). Some of the metabolites like glycine and glutamine
are known to be actively released into the blood with a
reported function (Ratnayake et al. 1997). Others like
carnitines seem to leak out of for example muscle cells
with a decreased mitochondrial activity (data not shown).
The PCaa and PCae as well as SM molecules are supposed
to be part of the cell membrane and so their leakage into
the blood stream can be a direct consequence of membrane
damage caused by substances in ETS especially of blood
cells, where it is also reported to alter the lipid composition
(Gangopadhyay et al. 2012; Padmavathi et al. 2010). Then
one would expect that the profile of lipids resembles their
occurrence of in the membrane. This assumption would
also demand for only up-regulation of lipid-related mole-
cules and not for an ETS specific down-regulation as it was
found in this study and earlier for specific lipids also by
Wang-Sattler et al. (2008b). Furthermore, in studies on the
serum metabolome of diabetes patients also changes of
PCaa and PCae were detected (Suhre et al. 2010) and
correlated with the known disturbed lipid homeostasis in
diabetic patients. The underlying details like which organ
is secreting which lipid by which mechanism will be an
important research question for the future.
The mechanistic link from an altered metabolism early in
life towards health effects later in life is given by metabo-
lomic programming, describing the hypothesis that e.g.
nutritional impact early in life has long reaching conse-
quences (Godfrey and Barker 2000). Beside nutrition as an
exogenous factor also tobacco smoke exposure may affect
the metabolome with consequences for the disease risk. In
the case of nicotine this has been proven since in mice the
maternal nicotine exposure resulted in increased postnatal
body weight and higher levels of body fat in the foetus (Gao
et al. 2005; Somm et al. 2008). This is in contrast to the
findings in humans, where smoking generally leads to a
reduced body weight of new-borns of smoking mothers. But
this effect is reported to be overcompensated by increased
rates of weight gain, which seem to result in an increased risk
for metabolic disorders (Harrod et al. 2015).
These effects of smoking direct the attention towards
effects on the central endocrine control of body weight
homeostasis, which might be explained by nicotine
dependent alterations in expression of neuropeptide Y and
propiomelanocortin (Grove et al. 2001). Also in toxico-
logical studies on foetal rats an influence of maternal
nicotine exposure has led to alterations in the hypothala-
mus–pituitary–adrenal axis with consequences on expres-
sion levels of 11ß-hydroxysteroid dehydrogenase-2,
glucocorticoid receptor and insulin-like growth factor, the
corresponding IGF-1 receptor and insulin receptor in the
foetal liver (Xu et al. 2012). Following answers of our
hypotheses are possible. Mothers and children show dif-
ferent regulation of metabolom. That is also affected by the
smoking behaviour of mothers. Urine cotinine measure-
ments are useful to describe the smoke behaviour of
mothers. It could be shown, that the antioxidative status of
lipid soluble fraction is is negative influenced by smoking.
4.4 Known limitations of this study
Serum samples from mothers and babies were collected at
different time points. This may lead to inconsistencies,
because metabolite concentrations may differ between 34th
week of pregnancy (sample taken from mother) and day of
birth (sample taken from cord blood). Due to ethical reasons
we don’t asked the mothers for a blood sample during birth
process. Despite of this limitation, we assume a steady state
of smoking related metabolites during this time frame.
5 Conclusion
With this study we demonstrate that serum from cord blood
has become a suitable medium for metabolomic profiling
that provides valuable information on the foetal metabo-
lism. Furthermore, we describe effects of ETS on the foetal
metabolome which is affected in a different way than the
maternal metabolome, pointing also to different underlying
mechanisms in adults and newborn children.
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